Rare diseases
Investigational molecules
Locations
Back to Spain299 clinical trials in Pozuelo De Alarcon, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study on BI 1839100 for Reducing Cough in Patients with Idiopathic or Progressive Pulmonary Fibrosis
SpainStudy Comparing Teclistamab, Talquetamab, and Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Not Suitable for Stem Cell Transplant
SpainStudy on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases
SpainStudy of CLN-081 tablets in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations who have previously received platinum chemotherapy
SpainStudy of OMX-0407 for Patients with Previously Treated Unresectable Solid Tumors
SpainStudy on the Effects of Camlipixant in Adults with Refractory or Unexplained Chronic Cough
SpainSafety Study of Almagate for Pregnant Women with Heartburn and Reflux, Assessing Effects on Mother and Baby
SpainStudy of Erlotinib and LY2875358 for Patients with Metastatic Non-Small Cell Lung Cancer with EGFR Mutations After Initial Erlotinib Treatment
SpainStudy of SCO-101 with FOLFIRI for Patients with Metastatic Colorectal Cancer Resistant to FOLFIRI
SpainStudy on the Effectiveness and Safety of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis
SpainStudy Comparing MK-2870 with Chemotherapy (Docetaxel or Pemetrexed) for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutations
SpainStudy of MK-7684A and Pembrolizumab for Patients with Advanced Solid Tumors
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on multiple cancer types including bladder cancer, pancreatic adenocarcinoma, and non-small cell lung cancer. Studies evaluate novel combination therapies and targeted treatments.
Research includes immunotherapy approaches and antibody-drug conjugates for improved treatment outcomes.
Clinical investigations in respiratory conditions, including studies of RSV prevention in high-risk infants and novel treatments for uncontrolled asthma. Research focuses on innovative therapeutic approaches.
Studies evaluate both preventive measures and treatment interventions.
Research targeting neurological conditions, with emphasis on Alzheimer's Disease and Multiple Sclerosis. Studies focus on disease-modifying therapies and novel treatment approaches.
Investigations aim to slow disease progression and improve patient outcomes.
Studies in blood disorders including acute myeloid leukemia and immune thrombocytopenia. Research evaluates new therapeutic approaches and combination treatments.
Focus on improving survival rates and treatment efficacy.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
